Therefore, these results suggest that KEAP1 mutations might favor tumorigenesis in part by enhancing the stability of the oncoprotein SOX9, at least in the lung carcinoma and HCC setting (Figure 8L). Here, SOX9 is linked to hepatocellular carcinoma.